| Literature DB >> 34124597 |
Nick Dua1, Mattias Fyrenius2, Deborah L Johnson1,3, Walter H Moos4,5.
Abstract
Given the disruption caused by the COVID-19 pandemic, life as we knew it has been turned upside down, but the need for science to go on has never been stronger. In the realm of scientific conferences, with the requirement for social distancing, the importance of wearing face coverings, and travel restrictions, only virtual meetings have been possible during the pandemic. But many are asking: What is the new post-pandemic normal likely to be? Do we still want to have in-person meetings when the restrictions are eased? Assuming we do, when will they be possible again, and under what conditions? Regardless of what the benefits of virtual symposia might be, are they here to stay? These questions, and many more that are being asked around the world today, are the subject of this perspective. Herein, we attempt to provide useful context and insight into where scientific meetings have been, where they are today, where they are going, and how they will get there. Our conclusion is that the pandemic has created an accelerated opportunity to make the world of future scientific conferences better in a "both/and" collaborative in-person/virtual scenario, not the more limited "pick one" choice.Entities:
Keywords: COVID‐19; conference; face‐to‐face; in‐person; meeting; scientific communication/interchange; symposia; virtual
Year: 2021 PMID: 34124597 PMCID: PMC8171307 DOI: 10.1096/fba.2020-00139
Source DB: PubMed Journal: FASEB Bioadv ISSN: 2573-9832
FIGURE 1Which would you prefer to attend, A and/or B? (A) How a poster session and a break during a conference looked before the COVID‐19 pandemic? (B) How virtual conferences look during the COVID‐19 pandemic in 2020?
A few examples of leading nonprofit conferences covering life sciences
| American Association for Cancer Research Meetings (AACR) | Cold Spring Harbor Conferences | Gordon Research Conferences |
| Federation of American Societies for Experimental Biology Meetings | Keystone Symposia | EMBO/EMBL Symposia |
Some challenges in doing science and holding meetings in the midst of a pandemic
| Disease outbreaks and lockdowns | Internet bandwidth limitations and computer crashes | Lack of clear national pandemic strategies in many countries |
| More limited support services | Quarantines | Restricted travel |
| Social distancing | Stress in general | Transition to new online tools that may still have bugs |
| Disruption of clinical trials | Limited access to academic research laboratories | Difficulty in obtaining needed resources for conducting research |
Potential advantages of virtual symposia
| Lower cost for registration | More people can attend from around the world | Lower carbon footprint |
| New collaboration technologies | More accessible to individuals with disabilities | Easier for people with dependents (including children) to attend |
| Maybe less intimidating for students to engage with leaders in their fields | Mitigates the risk of contracting COVID−19 and other illnesses | Eliminates travel time and expenses |
Possible issues with virtual symposia
| Can organizers and providers make the economics work? | Internet connections can be unstable, especially for high bandwidth needs | Poster sessions may struggle to achieve the richness of in‐person discussions |
| Less serendipity? | Large time zone differences if participating in real time | Lack of complete immersion in the conference |
What organizers might consider when canceling or rescheduling in‐person meetings, or when repositioning from in‐person meetings to virtual conferences or vice versa
| What is the most responsible thing to do? | Do you have cancellation insurance at the event site? | Do you have travel cancellation insurance? |
| Will people attend? | Are the organizers willing? | Do you have sufficient financial support to at least break even? |
| How far in advance do you need to finalize the event? | Will speakers be willing to present their latest (often unpublished) data? | Can the meeting be held safely? |
| Are there any travel restrictions and quarantine requirements? | Are there competing meetings that need to be considered? | The unknown… |
Considerations for conducting hybrid virtual/in‐person meetings
| What is the cost of adding a virtual component? | Is there sufficient demand for a virtual component? | Will a virtual option cannibalize in‐person meeting attendance? |
| Will a virtual option provide increased access to the global community and early‐career investigators? | Is it important that the majority of organizers and speakers attend the in‐person meeting? | Should the virtual component be live or prerecorded? |
Selected health and safety considerations for resumption of in‐person symposia
| Adequate air flow and upgraded filtration systems | Box lunches but no buffet or other food sharing areas | Contactless systems wherever possible |
| Indoor/outdoor venues kept below normal occupancy | Face covering requirements with spare face coverings available | Medical professionals available onsite |
| More frequent and more extensive cleaning schedules | Proof of recent negative test for SARS CoV−2 | Ready access to hand sanitizers, soap, and water |
| Significant signage and other reminders | Social distancing including partitions where needed | Sufficient local hospital capacity |
| Unidirectional flow of attendees | Zero tolerance for safety infractions | Reschedule (or go virtual or cancel) if local/regional disease surges |